FDA Approved: CUVPOSA — Supplemental Application (Merz Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for CUVPOSA (glycopyrrolate) by Merz Pharmaceuticals, LLC. This action corresponds to NDA 022571 and updates the pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Sialorrhea

Drugs mentioned

• CUVPOSA (glycopyrrolate)

Snippet

SUPPL AP for CUVPOSA (GLYCOPYRROLATE)